NCT01130103View on ClinicalTrials.gov

Combination Treatment for Posttraumatic Stress Disorder (PTSD) After the World Trade Center (WTC) Attack

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

Paroxetine

Paroxetine (controlled release) 12.5-50 milligrams (mg) daily for 22 weeks

BEHAVIORAL

Prolonged Exposure Therapy

Weekly for 10 weeks

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Research Foundation for Mental Hygiene, Inc.

OTHER

NCT01130103 - Combination Treatment for Posttraumatic Stress Disorder (PTSD) After the World Trade Center (WTC) Attack | Biotech Hunter | Biotech Hunter